Corrigendum to “Baseline metabolite profiles predict the glucose-lowering efficacy of exenatide in patients with type 2 diabetes” [Metabol Open. 2026, 29, 100453]

Metabolism Open · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles